LOS ANGELES, CA / ACCESSWIRE / December 2, 2016 / BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, announced today that it will be presenting at the 9th annual LD Micro Main Event on Tuesday, December 6 at 9:30 AM PST/ 12:30 PM EST in Track 5.
The Company's President, CEO and Director, Brady Granier, will be presenting and holding one-on-one meetings with investors throughout the day.
The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature 240 presenting names.
View the BioCorRx Inc. profile here: http://www.ldmicro.com/profile/BICX
News Compliments of Accesswire.
About BioCorRx
BioCorRx Inc. (OTC PINK: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx Inc. is a one-on-one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The Company also has an R&D subsidiary, BioCorRx Pharmaceuticals, which is currently developing a new injectable naltrexone technology (BICX101) through a partnership with TheraKine Ltd. The company plans to seek FDA approval for BICX101.
For more information on BICX, visit www.BioCorRx.com.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.
For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com/events for more information.
Contact:
BioCorRx Inc.
[email protected]
714-462-4880
Investor Relations:
MZ North America
Mike Cole
Vice President
Main: 949-259-4988
[email protected]
www.mzgroup.us